News

The federal government had challenged the request, arguing that insurers shouldn't get class-action status because their alleged damages would vary.

In the nation's most populous state, lawmakers are not content simply to resist efforts to dismantle the ACA but are fighting to expand health coverage.

The Pharmaceutical Research and Manufacturers of America spent $9.96 million on federal lobbying in the first three months of 2018.

An epilepsy specialist calls the drug, which is based on the marijuana plant, a potential 'life-changer' for some.

The new digital health platform is expected to pilot in Philadelphia in the second half of this year, providing an educational component and telemedicine capabilities.

Illinois is kicking the insurer out of its Medicaid managed-care program, accusing the insurer of failing to meet several key standards.